Cimpress CEO Sells $7 Million in Company Stock: What You Need to Know
Cimpress plc (NASDAQ:) CEO Robert S. Keane recently made headlines by selling a substantial amount of company stock, totaling over $7 million. The transactions, which occurred on August 29th and 30th, involved the sale of Cimpress ordinary shares at various prices.
According to the latest filings, Keane sold a total of 24,912 shares at a price of $98.195, among other transactions. These sales were conducted indirectly through Third Delaware 2011, LLC, an entity associated with Keane.
The total value of the shares sold amounted to approximately $7,051,345. Despite these sales, Keane still holds a significant interest in the company through various holdings.
These transactions were disclosed in compliance with SEC regulations, providing transparency for investors and the market. In other news, Cimpress reported a strong finish to fiscal year 2024, with positive growth in revenue and adjusted EBITDA.
The company also revealed plans for increased capital expenditures and growth in organic revenue and adjusted EBITDA. Investors may find it valuable to consider Cimpress's financial health and market performance, as highlighted by InvestingPro.
Cimpress boasts a robust gross profit margin, active share buybacks, and a reasonably valued P/E ratio. For more insights and analysis, visit InvestingPro's website. Stay informed and make informed investment decisions.
Analysis:
- CEO Robert S. Keane sold over $7 million in Cimpress stock, raising questions about the company's future.
- Cimpress reported positive financial results for fiscal year 2024, with plans for increased investments and growth.
- Investors should consider Cimpress's financial health, market performance, and valuation metrics before making investment decisions.